Japan's leading printer and photocopier maker Konica Minolta Inc. announced at the company will be acquiring Ambry Genetic Corp. - a US diagnostic company, in a deal valued at up to USD 1 billion. This is one of the largest deals for Konica Minolta and the company will jointly carry out the acquisition with the funds provided by Innovation Network Corp of Japan. Konica Minolta, which has a market value of around $4 billion, will account for 60 percent of the investment and the Innovation Network Corp of Japan (INCJ) will provide for the remaining 40 percent. Both the companies intend to enter into the precision medicine segment which is expected to have a great potential for the treatment of cancer. KMI has its own diagnostic technique, utilising a High Sensitive Tissue Testing (HSTT) technology, while Ambry excels in genetic tests for breast, colon and cancers, heart and respiratory diseases, etc. Further, the company will combine its HSTT technology and Ambry's genetic diagnostic technology to offer high-standard cancer diagnostic services and aid the development of new reagents which will help produce new medicines. Talking about the acquisition, Shoei Yamana - Chief Executive Officer of Konica Minolta Inc., said, “Together with Ambry, we will have the most comprehensive set of diagnostic technologies for mapping an individual's genetic and biochemical makeup." The companies expect to complete the necessary procedure for the deal by the end of October, 2017 and post which, Ambry will become a subsidiary of KMI while Ambry's business will be continued in the US.
Toshiba Corp. on July 11 had a meeting with its main banks about the negotiation of the sale of its semiconductor memory business with the Japan-US-South Korea ally led by Innovation Network Corp. of Japan (INCJ). The top management of Toshiba explained the negotiation is stalemated because the ally has a difficulty on the roles of SK Hynix of South Korea, which seems to have a stronger interest in NAND type flash memory technology than the other have earlier expected because SK is behind Samsumg in the mass production for NAND memory while it has know-how in DRAM production, which lacks in Toshiba and thinks the company has a merit to join the ally and commit to Toshiba Memory’s production more aggressively. Toshiba revealed it has started to negotiate again with Western Digital and Hon Hai Precision. WD has proposed the acquisition by allying with U.S. fund Kohlberg Kravis Roberts (KKR & Co.), INCJ and Development Bank of Japan. Toshiba wants to decide the sale of Toshiba Memory by the end of March, 2018 in order to have excessive liabilities two years in a row which is to lead to the company going private.
Nikon Corp. announced on August 3 the financial results for the first quarter ending on June 30, reporting that the total revenue for the period gained a 0.6% year-on-year to 170.3 billion yen, profit in operation declined 31.1% to 12.4 billion yen and net profit down 39.5% to 8.89 billion yen. In the Imaging Products segment, sales of mid-class cameras such as the D7500, a digital SLR camera released in June this year were firm, with unit sales increasing significantly in the U.S. Accordingly, the performance in revenue and operating profit exceeded the planned targets, but compared to the last year, a decease in revenue and operating profit was recorded due to a product mix change caused by the stagnant demand for the D5 and the D500. The company sold 720,000 units of interchangeable-lens cameras, 1.08 million units of interchangeable lenses and 770,000 compact digital cameras. The company said the unit sales of compact digital cameras declined but the average unit price rose about 30%.